系统性硬化症皮肤是为软组织钙化预置的微环境:一个假说
本文提出假说:系统性硬化症(SSc)皮肤细胞外基质(ECM)的改变,包括微纤维网络破坏和I型胶原积聚,反映细胞表型变化并形成促进软组织钙化的预置微环境,SSc成纤维细胞获得促骨生成表型,特定驱动力促进组织矿化。
要点
- SSc相关钙化症影响20-40%患者,发病机制不明且无有效改善病情药物。
- SSc皮肤ECM改变包括微纤维网络破坏和I型胶原积聚。
- 假说认为SSc成纤维细胞促骨生成表型与ECM改变共同预置钙化微环境。
核心结论
- SSc皮肤病理改变反映细胞表型变化,形成促进软组织钙化的预置微环境。
研究设计与样本
- 本文为假说性文章,基于对SSc皮肤细胞外基质改变的分析提出机制假说。
主要发现
- 钙化症影响20-40%的SSc患者,与疾病病程、指端缺血和肢端骨质溶解相关。
- SSc皮肤ECM显著改变,包括微纤维网络破坏和I型胶原积聚。
- SSc成纤维细胞获得促骨生成表型,特定驱动力促进组织矿化。
临床怎么用
- 考虑ECM在疾病进展中的作用可能有助于阐明SSc相关钙化机制并指导未来治疗干预开发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Calcinosis cutis, defined as sub-epidermal deposition of calcium salts, is a major clinical problem in patients with SSc, affecting 20-40% of patients. A number of recognized factors associated with calcinosis have been identified, including disease duration, digital ischaemia and acro-osteolysis. Yet, to date, the pathogenesis of SSc-related calcinosis remains unknown, and currently there is no effective disease-modifying pharmacotherapy. Following onset of SSc, there are marked changes in the extracellular matrix (ECM) of the skin, notably a breakdown in the microfibrillar network and accumulation of type I collagen. Our hypothesis is that these pathological changes reflect a changing cellular phenotype and result in a primed microenvironment for soft tissue calcification, with SSc fibroblasts adopting a pro-osteogenic profile, and specific driving forces promoting tissue mineralization. Considering the role of the ECM in disease progression may help elucidate the mechanism(s) behind SSc-related calcinosis and inform the development of future therapeutic interventions.
引用
- Burgess KA, Herrick AL, Watson REB, et al. Systemic sclerosis skin is a primed microenvironment for soft tissue calcification-a hypothesis. Rheumatology (Oxford). 2021. PMID: 33585894. doi:10.1093/rheumatology/keab156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。